The Annual Thomas C. Merigan Jr. Lecture
2016
The Division of Infectious Diseases and Geographic Medicine host, Peter Piot, MD, in 2016.
2015
The Division of Infectious Diseases and Geographic Medicine host, Julie Overbaugh, PhD, in 2015.
2014
The Division of Infectious Diseases and Geographic Medicine host, Bruce Walker, MD, in 2014.
2013
The Division of Infectious Diseases and Geographic Medicine host, Thomas C. Quinn, MD, in 2013.
2012
The Division of Infectious Diseases and Geographic Medicine host, Anthony S. Fauci, MD, in 2012.
Each year the Division of Infectious Diseases and Geographic Medicine hosts the Thomas C. Merigan, Jr. Lecture. This endowed lectureship is in honor of Dr. Merigan, Professor Emeritus, and the former Chief of the division of Infectious Diseases at Stanford. Dr. Merigan is an internationally known virologist whose laboratory contributed the tests to measure HIV viral load, among many other notable achievements, and he trained many leaders in the field of infectious diseases. Each year, the lectureships brings a renowned scientist to speak about their work in infectious diseases at Medicine Grand Rounds. The first lecture, in 1994, was given by Dr. Jonas Salk.
1994 — Dr. Jonas Salk developed the first successful polio vaccine.
1997 — Dr. Baruch Blumberg was an American physician, geneticist, and co-recipient of the 1976 Nobel Prize in Physiology or Medicine for his work on the hepatitis B virus while an investigator at the NIH.
1998 — Dr. Robert Gallo is best known for his role in the discovery of the human immunodeficiency virus (HIV) as the infectious agent responsible for acquired immune deficiency syndrome (AIDS) and in the development of the HIV blood test.
1999 — Dr. Maurice Hilleman is known as one of the world's leading vaccinologists, having developed eight of the 14 vaccines routinely given for once-common childhood diseases.
2000 — Dr. Michael Oldstone has made significant advancements that have led to the understanding of viral persistence and immunity in the nervous system.
2002 — Harriet Robinson has a multi-protein clade B DNA/MVA vaccine in phase 2a clinical trials through the US HIV vaccine Trials Network (HVTN).
2006 — Dr. John Wennberg is a researcher of healthcare variations.
2007 — Dr. Lawrence Corey pioneered the development of antiviral therapy for human chronic viral infections.
2008 — Dr. Douglas Richman has made major clinical and laboratory contributions to the field of HIV/AIDS, which represent a model of translational medical research.
2009 — Dr. Mark Wainberg was the first to identify 3TC as an anti-viral drug effective against HIV in 1989, and has made multiple contributions to the field of HIV drug resistance.
2012 — Dr. Anthony "Tony" Fauci is an immunologist who has made substantial contributions to HIV/AIDS research and other immunodeficiencies, both as a scientist and as the head of the National Institute of Allergy and Infectious Diseases.
2013 — Dr. Thomas Quinn investigations have involved the study of the epidemiologic, virologic, immunologic features of HIV infection in Africa, the Caribbean, South America and Asia.
2014 — Dr. Bruce Walker leads an international research effort to understand how some rare people who are infected with HIV but have never been treated can fight the virus with their immune system.
2015 — Dr. Julie Overbaugh worked closely with investigators in Kenya for the past 2 decades, including on a number of studies of mother-to-child and heterosexual transmission of HIV-1.
2016 — Dr. Peter Piot is a known microbiologist for his research into Ebola and AIDs.
David L. Heymann is Professor of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine; Head of the Centre on Global Health Security at Chatham House, London and Chairman of the Board, Public Health England, UK. Previously he was the World Health Organization's Assistant Director-General for Health Security and Environment, and Representative of the Director-General for polio eradication.
Timeline of Speakers
- 1994 Jonas E. Salk, MD
- 1995 Karl Johnson, MD
- 1996 Robert Channock, MD
- 1997 Baruch Blumberg, MD
- 1998 Robert C. Gallo, MD
- 1999 Maurice R. Hilleman, PhD, DSc
- 2000 Michael B. A. Oldstone, MD
- 2001 Stanley N. Cohen, MD
- 2002 Harriet Robinson, PhD
- 2003 Richard D. Klausner, MD
- 2006 John E. Wennberg, MD, MPH
- 2007 Lawrence Corey, MD
- 2008 Douglas Richman, MD
- 2009 Mark Wainberg, PhD
- 2010 Caroline Hall, MD
- 2012 Anthony S. Fauci, MD
- 2013 Thomas C. Quinn, MD
- 2014 Bruce Walker, MD
- 2015 Julie Overbaugh, PhD
- 2016 Peter Piot, MD, PhD, FRCP
- 2017 David Heymann, MD
- 2018 Steven Holland, MD
MEDICAL GRAND ROUNDS
Wed., May 23, 2018, 8 a.m. – 9 a.m.
Li Ka Shing Center LKSC Conference Room, 1st Floor
“MYCOBACTERIAL DISEASES: BOTH SOUP AND NUTS”
Steven M. Holland, M.D.
The 2018 Merigan Lecturer
Steven M. Holland, M.D., is the Director of the Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). As Director, Dr. Holland provides overall executive direction and scientific leadership for the Division’s basic and clinical research activities. Prior to becoming Director, DIR, NIAID, Dr. Holland served NIAID as Chief of the Laboratory of Clinical and Infectious Diseases (LCID). Dr. Holland continues to lead a program in NIAID as chief of its Immunopathogenesis Section in the Laboratory of Clinical Immunology and Microbiology.
Dr. Holland’s research areas of special interest have included Job's syndrome (autosomal dominant STAT3 deficiency) and the genetic conditions predisposing people to mycobacterial infections. More recently, he has been interested in genetic conditions associated with severe coccidioidomycosis and acquired forms of anticytokine autoimmunity predisposing to opportunistic infections. Dr. Holland is the author of more than 500 publications and has been named an NIH Distinguished Investigator. He has received the Infectious Diseases Society of America’s Walter E. Stamm Mentor Award, the American College of Physicians Award for Science, the Boyle Scientific Achievement Award of the Immune Deficiency Foundation, the American Society for Microbiology Abbott Award, the Erwin Neter Award of the Association of Medical Laboratory Immunologists, and the NIH Distinguished Clinical Teacher Award, among other awards. He received his B.A. degree from St. John's College in Annapolis, Maryland, in 1979 and his M.D. degree from the Johns Hopkins University School of Medicine in 1983. He remained at Johns Hopkins for his internal medicine residency, chief residency, and fellowship in infectious diseases. He came to NIAID in 1989 to study the molecular biology of HIV, and in 1991 moved to the Laboratory of Host Defenses, NIAID, to study phagocytes and phagocyte immunodeficiencies. In 2004, he became chief of LCID, NIAID, a position he held until his appointment as Director, DIR in July 2016.
Events
Dr. Thomas C. Merigan, Professor Emeritus